An improved synthesis of psammaplin A

Bioorganic and Medicinal Chemistry Letters

Volumn 16, Issue 12, 2006, Pages 3330-3333

  Godert, Amy M ^a   Angelino, Norman ^a   Woloszynska Read, Anna ^a   Morey, Shannon R ^a   James, Smitha R ^a   Karpf, Adam R ^a   Sufrin, Janice R ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

5 Bromo psammaplin A; Cancer cells; DNA methylation; DNA methyltransferase; DNA methyltransferase inhibitor; Psammaplin A

Indexed keywords

DNA; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE INHIBITOR; NATURAL PRODUCT; PSAMMAPLIN A; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CONTROLLED STUDY; DNA METHYLATION; DRUG SCREENING; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; SPONGE (PORIFERA);

CELL LINE, TUMOR; DISULFIDES; DNA METHYLATION; ENZYME INHIBITORS; HUMANS; METHYLTRANSFERASES; MOLECULAR STRUCTURE; TYROSINE;

PORIFERA;

EID: 33646180176     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.03.008     Document Type: Article

References (23)

1. Arabshahi L., and Schmitz F.J. J. Org. Chem. 52 (1987) 3584
2. Jiang Y.H., Ahn E.Y., Ryu S.H., Kim D.K., Park J.S., Yoon H.J., You S., Lee B.J., and Jung J.H. BMC Cancer 4 (2004) 70
3. Jung J.H., Sim C.J., and Lee C.O. J. Nat. Prod. 58 (1995) 1722
4. Kim D., Lee I.S., Jung J.H., Lee C.O., and Choi S.U. Anticancer. Res. 19 (1999) 4085
5. Kim D.Y., Lee I.S., Jung J.H., and Yang S.I. Arch. Pharm. Res. 22 (1999) 25
6. Nicholas G.M., Eckman L.L., Ray S., Hughes R.O., Pfefferkorn J.A., Barluenga S., Nicolaou K.C., and Bewley C.A. Bioorg. Med. Chem. Lett. 12 (2002) 2487
7. Nicolaou K.C., Hughes R., Pfefferkorn J.A., Barluenga S., and Roecker A.J. Chem. Eur. J. 7 (2001) 4280
8. Nicolaou K.C., Hughes R., Pfefferkorn J.A., and Barluenga S. Chem. Eur. J. 7 (2001) 4296
9. Park Y., Liu Y., Hong J., Lee C.O., Cho H., Kim D.K., Im K.S., and Jung J.H. J. Nat. Prod. 66 (2003) 1495
10. Pina I.C., Gautschi J.T., Wang G.Y.S., Sanders M.L., Schmitz F.J., France D., Cornell-Kennon S., Sambucetti L.C., Remiszewski S.W., Perez L.B., Bair K.W., and Crews P. J. Org. Chem. 68 (2003) 3866
11. Shim J.S., Lee H.S., Shin J., and Kwon H. J. Cancer Lett. 203 (2004) 163
12. Shin J., Lee H.S., Seo Y., Rho J.R., Cho K.W., and Paul V.J. Tetrahedron 56 (2000) 9071
13. Tabudravu J.N., Eijsink V.G.H., Gooday G.W., Jaspars M., Komander D., Legg M., Synstad B., and van Aslten D.M.F. Bioorg. Med. Chem. Lett. 10 (2002) 1123
14. Jiminez C., and Crews P. Tetrahedron 47 (1991) 2097
15. Hoshino O., Murakata M., and Yamada K. Bioorg. Med. Chem. Lett. 2 (1992) 1561
16. Kotoku N., Tsujita H., Hiramatsu A., Mori C., Koizumi N., and Kobayashi M. Tetrahedron 61 (2005) 7211
17. Boehlow T.R., Harburn J.J., and Spilling C.D. J. Org. Chem. 66 (2001) 3111
18. Harburn J.J., Rath N.P., and Spilling C.D. J. Org. Chem. 70 (2005) 6398
19. Cimino G., De Stefano S., and Minali L. Experienta 31 (1975) 756
20. Fang M.Z., Wang Y., Ai N., Hou Z., Sun Y., Lu H., Welsh W., and Yang C.S. Cancer Res. 63 (2003) 7563
21. Song L.G., James S.R., Kazim L., and Karpf A.R. Anal. Chem. 77 (2005) 504
22. Christman J.K. Oncogene 21 (2002) 5483
23. Karpf A.R., Lasek A.W., Ririe T.O., Hanks A.N., Grossman D., and Jones D.A. Mol. Pharmacol. 65 (2004) 18